title: TRPV1: a therapeutic target for novel analgesic drugs?
abstract: The vanilloid receptor TRPV1 is now recognized as a molecular integrator of painful stimuli ranging from noxious heat to endovanilloids in inflammation. Pharmacological blockade of TRPV1 represents a new strategy in pain relief. TRPV1 antagonists are expected to prevent pain by silencing receptors where pain is generated rather than stopping the propagation of pain, as most-traditional pain killers do. This hypothesis has already being tested in the clinic by administering small molecule TRPV1 antagonists (e.g. GlaxoSmithKline SB-705498) for migraine and dental pain. Paradoxically, in some murine models of chronic pain, TRPV1-deficient mice exhibit more pain-related behavior than their wild-type littermates, indicating that the understanding of TRPV1 in pain is still incomplete. Moreover, there is mounting evidence to suggest the existence of functional TRPV1 both in the brain and in various non-neuronal tissues. The biological role of these receptors remains elusive, but their tissue distribution clearly indicates that they are involved in many more functions than just pain perception. Here, we review the potential therapeutic indications and adverse effects of TRPV1 antagonists.
authors.affiliation: Departments of Pathology, Monmouth Medical Center, Long Branch, NJ 07740, USA. aszallasi@sbhcs.com
authors.forename: Arpad
authors.initials: A
authors.lastname: Szallasi
authors.forename: Francisco
authors.initials: F
authors.lastname: Cruz
authors.forename: Pierangelo
authors.initials: P
authors.lastname: Geppetti
mesh_terms: D000700:Analgesics / Q000627:therapeutic use*; D000818:Animals; D018390:Gene Targeting / Q000379:methods*; D006801:Humans; D007249:Inflammation / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D008881:Migraine Disorders / Q000378:metabolism; D008954:Models, Biological; D009475:Neurons, Afferent / Q000378:metabolism; D010146:Pain / Q000209:etiology / Q000378:metabolism*; D015398:Signal Transduction; D050916:TRPV Cation Channels / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000378:metabolism / Q000502:physiology; D014018:Tissue Distribution; D001745:Urinary Bladder Diseases / Q000378:metabolism*
chemical_list: D000700:Analgesics; D050916:TRPV Cation Channels; C494482:TRPV1 protein, human